🇺🇸 PCRX — Pacira BioSciences, Inc.

Salud Mantener
← Volver

Precio actual

36,39 USD

Máx. histórico

119,27

4269 días

Caída desde máximo

-69,49%

Rango 52 semanas

18,80 – 36,67

Variación hoy

-0,03%

Cierre anterior

36,40

Rango de hoy

36,39 – 36,41

Volumen hoy

1.075.323

Peor caída histórica

-90,19%

25/02/2015 → 09/08/2024

Aún sin recuperar

Volatilidad anualizada ⓘ

50,36%

Información
Nombre completo
Pacira BioSciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
825
PER ⓘ
103,97 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
33,57 USD (puede no estar actualizado)
Primera cotización
03/02/2011
Precio actualizado
hace 13 horas
Sobre la empresa

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Brisbane, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
03/04/2023 40,72 41,58 40,70 41,37 +1,37% 2,16% 453.700
31/03/2023 40,61 40,92 40,36 40,81 +1,57% 1,38% 306.200
30/03/2023 41,01 41,44 39,80 40,18 -1,45% 4,00% 317.900
29/03/2023 40,31 40,90 39,64 40,77 +2,15% 3,13% 340.500
28/03/2023 39,87 40,40 39,24 39,91 -0,40% 2,91% 293.800
27/03/2023 39,78 40,30 39,32 40,07 +2,38% 2,46% 246.100
24/03/2023 38,21 39,26 37,63 39,14 +1,40% 4,27% 695.600
23/03/2023 39,60 39,94 38,48 38,60 -1,86% 3,69% 428.100
22/03/2023 40,27 40,44 39,23 39,33 -2,36% 3,00% 390.900
21/03/2023 40,32 40,99 39,82 40,28 +1,51% 2,90% 350.800
20/03/2023 39,63 40,19 39,23 39,68 +0,48% 2,42% 394.400
17/03/2023 41,42 41,54 39,30 39,49 -4,77% 5,41% 946.200
16/03/2023 39,17 41,72 39,15 41,47 +5,36% 6,56% 588.700
15/03/2023 38,55 39,81 38,42 39,36 +0,41% 3,61% 543.800
14/03/2023 39,47 39,74 38,81 39,20 +1,55% 2,36% 423.400
13/03/2023 39,49 40,65 38,51 38,60 -3,62% 5,42% 529.600
10/03/2023 39,50 40,80 39,18 40,05 +0,70% 4,10% 1.065.200
09/03/2023 39,76 40,04 39,27 39,77 +0,45% 1,94% 457.800
08/03/2023 40,62 40,62 39,19 39,59 -2,03% 3,52% 470.500
07/03/2023 40,81 41,21 40,11 40,41 -1,08% 2,70% 449.200
06/03/2023 42,09 42,09 40,48 40,85 -2,85% 3,83% 662.000
03/03/2023 42,64 43,98 40,99 42,05 -0,50% 7,01% 749.600
02/03/2023 43,04 43,09 42,11 42,26 -2,58% 2,28% 442.900
01/03/2023 43,10 44,42 42,12 43,38 +1,90% 5,34% 767.200
28/02/2023 41,64 44,53 40,52 42,57 +3,93% 9,63% 1.632.900
27/02/2023 41,00 41,92 40,20 40,96 -0,10% 4,20% 687.500
24/02/2023 41,38 41,68 40,54 41,00 -1,80% 2,75% 689.800
23/02/2023 42,44 43,46 41,42 41,75 -1,30% 4,81% 445.200
22/02/2023 41,07 42,54 40,60 42,30 +2,82% 4,72% 767.600
21/02/2023 41,60 41,96 40,73 41,14 -1,81% 2,96% 581.100